Meet us in Fiera Milano at the
Fiera Milano Rho, Booth #8L68

cphi-milan-featured

Why CPHI Europe Matters

CPHI Milan brings together pharmaceutical companies, CDMOs, and industry leaders advancing drug development and manufacturing from early discovery through commercial supply. The conference highlights the chemistry, process development, manufacturing, and supply chain capabilities required to bring small molecule and complex therapeutics to market at scale.

Adesis is a U.S.-based CDMO specializing in small-molecule organic synthesis, supporting pharmaceutical companies across discovery, development, and manufacturing. With expanded manufacturing capabilities in Ireland, we help programs transition efficiently from early-stage chemistry through process optimization and ongoing commercial supply. We attend CPHI Europe to connect with pharmaceutical teams and discuss how we can support their development and manufacturing challenges.

Learn more about the event at https://www.cphi.com/europe/.

cphi-milan-featured

Meet the Adesis Team at CPHI Europe

Our team will be onsite throughout CPHI Europe to meet with pharmaceutical companies advancing small molecule and complex therapeutic programs.

If you’re exploring partners for:

Heterocycles and regulatory starting materials (RSMs)

Linear and cyclic peptides or oligonucleotides

Deuterated drug products

Small molecule linkers for PROTACs, ADCs, and other modalities

Process chemistry, scale-up, and commercial manufacturing

we would welcome the opportunity to connect.

What We Do

Who We Are

Adesis is a U.S.-based contract development and manufacturing organization (CDMO) focused on complex small-molecule and peptide chemistry. We partner with pharmaceutical and biotechnology companies to advance programs from early discovery through specialty manufacturing with precision, speed, and reliability.

With more than 100,000 square feet of laboratory and manufacturing space across two Delaware sites, supported by additional manufacturing capacity in Ireland, and a scientific team comprised of over 100 chemists (approximately 80% PhD-level), Adesis operates as a seamless extension of client R&D organizations—bringing deep technical expertise across small molecules and peptides, rigorous quality systems, and practical execution to every program.

Accelerate

Your Success

Learn More About Adesis

Let's Stay Connected

Beyond the Conference

Follow Us